Summary
49 / 100 · Bulios Score
What speaks for it
- It has raised its dividend 14 years in a row and pays out only 59% of profit.
- It has been profitable 6 years in a row.
What to watch
- Earnings per share fell by 19% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 21.6 USD for 1 USD of yearly profit. Over the last five years it was 30.1 USD on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 0.1% a year over 5 years. Over the last 3 years it fell by 1.4% a year. For the next fiscal year analysts expect revenue to grow by 4.9%. Earnings per share fell by 19% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 68 USD
- Sales and administration 22 USD
- Taxes and other 4.5 USD
- Net profit 5.2 USD
Net profit, industry median (Chemicals - Specialty) 5.9 USD
Out of every 100 USD of revenue, 5.2 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 34.4 years of free cash flow. Its debt is larger than its cash. The debt score is high even so.
Financial health in detailDoes it pay a dividend?
Moderate, at risk- Yield
- 2.71%
- Paid out of profit
- 59%
- Raised in a row
- 14 years
You receive $1.10 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 13
- Hold 8
- Sell 0
Today's price within the analysts' price targets
The average target of $47.75 is 16% above today's price. 62% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Color Additives And Inks 62%
- Specialty Engineered Materials 38%
By region
- United States And Canada 40%
- EMEA 36%
- Asia 18%
- Latin America 5.6%
Color Additives And Inks brings in 62% of revenue.
Segments in detail